Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459681 | 12745968 | 1 | I | 2016 | 20160912 | 20160915 | 20160915 | EXP | US-GLAXOSMITHKLINE-US2016GSK133745 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459681 | 12745968 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), BID | U | 6ZP5391 | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 127459681 | 12745968 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), QD | U | 21077 | 1 | DF | INHALATION POWDER | QD | ||||||
| 127459681 | 12745968 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | Z69F | 0 | |||||||||
| 127459681 | 12745968 | 4 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 127459681 | 12745968 | 5 | SS | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | UNK | U | R763531 | 0 | INHALATION POWDER | ||||||||
| 127459681 | 12745968 | 6 | SS | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | U | 0 | INHALATION POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127459681 | 12745968 | 1 | Chronic obstructive pulmonary disease |
| 127459681 | 12745968 | 2 | Asthma |
| 127459681 | 12745968 | 3 | Chronic obstructive pulmonary disease |
| 127459681 | 12745968 | 4 | Asthma |
| 127459681 | 12745968 | 5 | Chronic obstructive pulmonary disease |
| 127459681 | 12745968 | 6 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127459681 | 12745968 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127459681 | 12745968 | Incorrect dose administered | |
| 127459681 | 12745968 | Intentional product use issue | |
| 127459681 | 12745968 | Macular degeneration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127459681 | 12745968 | 1 | 2012 | 0 | ||
| 127459681 | 12745968 | 3 | 2010 | 0 | ||
| 127459681 | 12745968 | 5 | 2016 | 0 |